About Us
Our Mission
Infogene's business is to research, develop, manufacture and market new tests and services for the early detection of cancer using non-invasive methods.
Our Skills
KNOW-HOW
Infogene has a highly qualified technical staff in genetics, molecular virology and oncology, with more than 15 years of experience in the field of molecular cancer research. The team consists of researchers with PhDs in genetics and molecular virology and technicians with degrees and masters in life sciences (biochemistry and pharmaceutical biotechnology). Infogene is nationally and internationally one of the most competent laboratories for the performance of molecular tests for the detection and genotyping of human papillomavirus (HPV) and other sexually transmitted diseases, as well as for the development of research projects, from project planning to the laboratory performance and data processing.
TECHNOLOGY
Our laboratory applies the most advanced technologies for molecular diagnosis, such as polymerase chain reaction (PCR), quantitative real-time PCR (qPCR), digital PCR, DNA arrays, and DNA sequencing.
QUALITY
Infogene periodically participates in external quality assessment programs (EHEQAS, ICOVEQAS and PNAEQ SARS-CoV-2). With regard to HPV detection/genotyping services, the results obtained have always been excellent. Infogene is therefore a laboratory of excellence at the European level. In 2015, Infogene began to be externally audited by SGS and, in 2018, renewed its certification and transitioned to the new NP EN ISO 9001:2015 standard for the following activities: (i) Research and development in early cancer detection, (ii) Wholesale distribution of medical devices, and (iii) Provision of early cancer detection services through molecular biology. The next focus was the integration of the NP EN ISO 13485:2017 standard into the Quality Management System (QMS), which took place in 2021 through APCER, covering another company activity: the manufacture of medical devices. Thus, Infogene’s QMS currently complies with the requirements of the NP EN ISO 9001:2015 and ISO 13485:2016 standards for the activities of research and development in early cancer detection, manufacture and wholesale distribution of medical devices and in vitro diagnostic medical devices, and the provision of early cancer detection services through molecular biology. Infogene is licensed by the Health Regulatory Authority (ERS) to operate as a laboratory in the areas of clinical pathology and clinical analyses – molecular pathology (excluding human genetics), under Operating License No. 25735/2025, reinforcing its commitment to compliance with applicable legal and regulatory requirements.
Company.our_quality_policy_title
The implementation and management of the quality system is a mechanism for improving Infogene’s organizational structure, which is currently small in size and relies on highly versatile human resources.
The quality policy is oriented towards complying with the legal requirements established by the regulatory agencies that oversee the company’s activities.
Quality is instrumental in increasing the accuracy of laboratory analyses and promoting the scientific credibility of the products developed and services provided by Infogene.
Infogene acknowledges its commitment to sustainable development, aligning with the United Nations Sustainable Development Goals. To this end, it incorporates into its operations practices that promote environmental responsibility, including:
- the proper and responsible management of laboratory waste,
- the systematic recycling of materials whenever possible,
- the reduction of natural and energy resource consumption,
- and ensuring that all electronic equipment that can be turned off is indeed switched off outside working hours, contributing to energy savings.
Additionally, Infogene values the promotion of health and well-being by ensuring a safe, inclusive, and socially healthy working environment. All employees actively participate in the company’s decision-making, fostering inclusion, transparency, and team spirit.
In terms of resource efficiency, the company strives to keep processes digital whenever possible, aiming to minimize paper use and reduce waste, integrating digitalization as part of its commitment to sustainability.
Finally, the quality system is an essential mechanism to ensure the satisfaction of our partners and clients, within a framework of continuous improvement of processes, products, and services.
